nach oben

Die Ophthalmologie

Erschienen in:

25.05.2018 | Streptokokken | CME

Endophthalmitis

verfasst von: PD Dr. Thomas Neß

Erschienen in: Die Ophthalmologie | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Zusammenfassung

Eine Endophthalmitis ist eine schwere Infektion des Augapfels mit der Gefahr einer Erblindung oder eines Augapfelverlusts. Man unterscheidet eine exogene (postoperative oder posttraumatische) Endophthalmitis von der endogenen Endophthalmitis. Häufigster Grund einer exogenen Endophthalmitis ist eine vorausgegangene Kataraktoperation oder eine intravitreale Medikamenteninjektion. Typische Symptome sind Visusverlust und Schmerzen. Hypopyon und Glaskörperinfiltration mit Verlust des Fundusrots sind die wichtigsten klinischen Befunde für eine Endophthalmitis. Die Diagnose ist primär klinisch, die mikrobiologische Diagnostik aus Vorderkammer und/oder Glaskörper unterstützt die Diagnose und hilft bei einer zielgerichteten Therapie. Basis der Therapie ist die Gabe von intraokulären, in der Regel intravitrealen Antibiotika, oft in Kombination mit einer Vorderkammerspülung und/oder Vitrektomie. Systemische Antibiotika können unterstützend gegeben werden. Der entscheidende Faktor für die Prognose ist der auslösende Keim. Infektionen mit koagulasenegativen Staphylokokken oder Candida spp. haben eine gute Prognose. Infektionen mit Streptokokken, Bacillus spp. oder Aspergillus spp. sind ungünstig.

Durand ML (2017) Bacterial and fungal endophthalmitis. Clin Microbiol Rev 30:597–613CrossRefPubMedPubMedCentral

Ness T, Pelz K, Hansen LL (2007) Endogenous endophthalmitis: microorganisms, disposition and prognosis. Acta Ophthalmol Scand 85:852–856 (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17725616)CrossRefPubMed

Endophthalmitis Vitrectomy Study Group (1995) Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 113:1479–1496. Verfügbar unter: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7487614 CrossRef

Vaziri K, Schwartz SG, Kishor K, Flynn HW (2015) Endophthalmitis: state of the art. Clin Ophthalmol 9:95–108PubMedPubMedCentral

Taban M, Behrens A, Newcomb RL, Nobe MY, Saedi G, Sweet PM et al (2005) Acute endophthalmitis following cataract surgery: a systematic review of the literature. Arch Ophthalmol 123:613–620 (Verfügbar unter: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15883279)CrossRefPubMed

Ness T, Feltgen N, Agostini H, Bohringer D, Lubrich B (2010) Toxic vitreitis outbreak after intravitreal injection. Retina 30:332–338 (Verfügbar unter: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20175274)CrossRefPubMed

Ness T, Kern WV, Frank U, Reinhard T (2011) Postoperative nosocomial endophthalmitis: Is perioperative antibiotic prophylaxis advisable? A single cengter’s experience. J Hosp Infect 78:138–142CrossRefPubMed

Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons (2007) Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 33:978–988 (Verfügbar unter: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17531690)CrossRef

Johnson MW, Doft BH, Kelsey SF, Barza M, Wilson LA, Barr CC et al (1997) The Endophthalmitis Vitrectomy Study. Relationship between clinical presentation and microbiologic spectrum. Ophthalmology 104:261–272CrossRefPubMed

10.

Ness T, Pelz K (2000) Endophthalmitis: improvement of culture results. Ophthalmologe 97:33–37 (Verfügbar unter: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10663787)CrossRefPubMed

11.

Sharma S, Sahu SK, Dhillon V, Das S, Rath S (2015) Reevaluating intracameral cefuroxime as a prophylaxis against endophthalmitis after cataract surgery in India. J Cataract Refract Surg 41:393–399CrossRefPubMed

12.

Hatch WV, Cernat G, Wong D, Devenyi R, Bell CM (2009) Risk factors for acute endophthalmitis after cataract surgery: a population-based study. Ophthalmology 116:425–430 (Verfügbar unter: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19091417)CrossRefPubMed

13.

Fileta JB, Scott IU, Flynn HW (2014) Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmic Surg Lasers Imaging Retin 45(9):143CrossRef

14.

Bhavsar AR, Sandler DR (2015) Eliminating antibiotic prophylaxis for intravitreal injections: a consecutive series of 18,839 injections by a single surgeon. Retina Phila Pa 35:783–788CrossRef

15.

Dossarps D, Bron AM, Koehrer P, Aho-Glélé LS, Creuzot-Garcher C, FRCR net (FRenCh Retina specialists net) (2015) Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome. Am J Ophthalmol 160:17–25.e1CrossRefPubMed

16.

Lyall DA, Tey A, Foot B, Roxburgh STD, Virdi M, Robertson C et al (2012) Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes. Eye Lond Engl 26:1517–1526CrossRef

17.

McCannel CA (2011) Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina Phila Pa 31:654–661CrossRef

18.

Goldberg RA, Flynn HW Jr, Isom RF, Miller D, Gonzalez S (2012) An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab. Am J Ophthalmol 153:204–208e1 (Verfügbar unter: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=22264943)CrossRefPubMedPubMedCentral

19.

Moshfeghi AA, Rosenfeld PJ, Flynn HW, Schwartz SG, Davis JL, Murray TG et al (2011) Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center. Retina Phila Pa 31:662–668CrossRef

20.

Roth DB, Flynn HW (2008) Distinguishing between infectious and noninfectious endophthalmitis after intravitreal triamcinolone injection. Am J Ophthalmol 146:346–347CrossRefPubMed

21.

Dave VP, Pathengay A, Schwartz SG, Flynn HW (2014) Endophthalmitis following pars plana vitrectomy: a literature review of incidence, causative organisms, and treatment outcomes. Clin Ophthalmol 8(8):2183PubMedPubMedCentral

22.

Scott IU, Flynn HW Jr, Dev S, Shaikh S, Mittra RA, Arevalo JF et al (2008) Endophthalmitis after 25-gauge and 20-gauge pars plana vitrectomy: incidence and outcomes. Retina 28:138–142 (Verfügbar unter: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18185150)CrossRefPubMed

23.

Brillat-Zaratzian E, Bron A, Aptel F, Romanet JP, Cornut PL, Vandenesch F et al (2014) FRIENDS Group: clinical and microbiological characteristics of post-filtering surgery endophthalmitis. Graefes Arch Clin Exp Ophthalmol 252:101–107CrossRefPubMed

24.

Busbee BG, Recchia FM, Kaiser R, Nagra P, Rosenblatt B, Pearlman RB (2004) Bleb-associated endophthalmitis: clinical characteristics and visual outcomes. Ophthalmology 111:1495–1503 (discussion 1503)CrossRefPubMed

25.

Yamamoto T, Sawada A, Mayama C, Araie M, Ohkubo S, Sugiyama K et al (2014) The 5‑year incidence of bleb-related infection and its risk factors after filtering surgeries with adjunctive mitomycin C: collaborative bleb-related infection incidence and treatment study 2. Ophthalmology 121:1001–1006CrossRefPubMed

26.

Alwitry A, King AJ (2012) Surveillance of late-onset bleb leak, blebitis and bleb-related endophthalmitis – a UK incidence study. Graefes Arch Clin Exp Ophthalmol 250:1231–1236CrossRefPubMed

27.

Wallin Ö, Al-ahramy AM, Lundström M, Montan P (2014) Endophthalmitis and severe blebitis following trabeculectomy. Epidemiology and risk factors; a single-centre retrospective study. Acta Ophthalmol 92:426–431CrossRefPubMed

28.

Sharan S, Trope GE, Chipman M, Buys YM (2009) Late-onset bleb infections: prevalence and risk factors. Can J Ophthalmol 44:279–283 (Verfügbar unter: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19491982)CrossRefPubMed

29.

Lehmann OJ, Bunce C, Matheson MM, Maurino V, Khaw PT, Wormald R et al (2000) Risk factors for development of post-trabeculectomy endophthalmitis. Br J Ophthalmol 84:1349–1353CrossRefPubMedPubMedCentral

30.

Leng T, Miller D, Flynn HW, Jacobs DJ, Gedde SJ (2011) Delayed-onset bleb-associated endophthalmitis (1996–2008): causative organisms and visual acuity outcomes. Retina Phila Pa 31:344–352CrossRef

31.

Alharbi SS, Alrajhi A, Alkahtani E (2014) Endophthalmitis following keratoplasty: incidence, microbial profile, visual and structural outcomes. Ocul Immunol Inflamm 22:218–223CrossRefPubMed

32.

Chen JY, Jones MN, Srinivasan S, Neal TJ, Armitage WJ, Kaye SB et al (2015) Endophthalmitis after penetrating keratoplasty. Ophthalmology 122:25–30CrossRefPubMed

33.

Andreoli CM, Andreoli MT, Kloek CE, Ahuero AE, Vavvas D, Durand ML (2009) Low rate of endophthalmitis in a large series of open globe injuries. Am J Ophthalmol 147:601–608.e2CrossRefPubMed

34.

Li X, Zarbin MA, Bhagat N (2015) Pediatric open globe injury: a review of the literature. J Emerg Trauma Shock 8:216–223CrossRefPubMedPubMedCentral

35.

Nicoară SD, Irimescu I, Călinici T, Cristian C (2014) Outcome and prognostic factors for traumatic endophthalmitis over a 5-year period. J Ophthalmol 2014:747015PubMedPubMedCentralCrossRef

36.

Parke DW, Pathengay A, Flynn HW, Albini T, Schwartz SG (2012) Risk factors for endophthalmitis and retinal detachment with retained intraocular foreign bodies. J Ophthalmol 2012:758526CrossRefPubMedPubMedCentral

37.

Bhagat N, Nagori S, Zarbin M (2011) Post-traumatic infectious endophthalmitis. Surv Ophthalmol 56:214–251CrossRefPubMed

38.

Jindal A, Pathengay A, Mithal K, Jalali S, Mathai A, Pappuru RR et al (2014) Endophthalmitis after open globe injuries: changes in microbiological spectrum and isolate susceptibility patterns over 14 years. J Ophthalmic Inflamm Infect 4:5CrossRefPubMedPubMedCentral

39.

Callegan MC, Kane ST, Cochran DC, Novosad B, Gilmore MS, Gominet M et al (2005) Bacillus endophthalmitis: roles of bacterial toxins and motility during infection. Invest Ophthalmol Vis Sci 46:3233–3238CrossRefPubMed

40.

Okada AA, Johnson RP, Liles WC, D’Amico DJ, Baker AS (1994) Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study. Ophthalmology 101:832–838 (Verfügbar unter: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8190467)CrossRefPubMed

41.

Jackson TL, Paraskevopoulos T, Georgalas I (2014) Systematic review of 342 cases of endogenous bacterial endophthalmitis. Surv Ophthalmol 59:627–635CrossRefPubMed

42.

Chen KJ, Hwang YS, Chen YP, Lai CC, Chen TL, Wang NK (2009) Endogenous Klebsiella endophthalmitis associated with Klebsiella pneumoniae pneumonia. Ocul Immunol Inflamm 17:153–159 (Verfügbar unter: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19585357)CrossRefPubMed

43.

Oude Lashof AML, Rothova A, Sobel JD, Ruhnke M, Pappas PG, Viscoli C et al (2011) Ocular manifestations of candidemia. Clin Infect Dis 53:262–268CrossRefPubMed

44.

Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L et al (2016) Clinical practice guideline for the management of Candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis 62:e1–50CrossRefPubMed

45.

Chiquet C, Cornut P‑L, Benito Y, Thuret G, Maurin M, Lafontaine P‑O et al (2008) Eubacterial PCR for bacterial detection and identification in 100 acute postcataract surgery endophthalmitis. Invest Ophthalmol Vis Sci 49:1971–1978CrossRefPubMed

46.

Behrens-Baumann W, Frank U, Ness T (2010) Rational antibiotic therapy in ophthalmology. Ophthalmologe. https://doi.org/10.1007/s00347-009-2077-z (Verfügbar unter: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20145935)PubMedCrossRef

47.

Hooper CY, Lightman SL, Pacheco P, Tam PM, Khan A, Taylor SR (2012) Adjunctive antibiotics in the treatment of acute bacterial endophthalmitis following cataract surgery. Acta Ophthalmol. https://doi.org/10.1111/j.1755-3768.2011.02365.x (Verfügbar unter: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=22429465)PubMedCrossRef

48.

Kim CH, Chen MF, Coleman AL (2017) Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD012131.pub2 PubMedCentralCrossRefPubMed

49.

Manning S, Ugahary LC, Lindstedt EW, Wubbels RJ, van Dissel JT, Jansen JTG et al (2017) A prospective multicentre randomized placebo-controlled superiority trial in patients with suspected bacterial endophthalmitis after cataract surgery on the adjuvant use of intravitreal dexamethasone to intravitreal antibiotics. Acta Ophthalmol. https://doi.org/10.1111/aos.13610 CrossRefPubMedPubMedCentral

50.

Gan IM, Ugahary LC, van Dissel JT, Feron E, Peperkamp E, Veckeneer M et al (2005) Intravitreal dexamethasone as adjuvant in the treatment of postoperative endophthalmitis: a prospective randomized trial. Graefes Arch Clin Exp Ophthalmol 243:1200–1205CrossRefPubMed

51.

Behndig A, Cochener B, Güell JL, Kodjikian L, Mencucci R, Nuijts RMMA et al (2013) Endophthalmitis prophylaxis in cataract surgery: overview of current practice patterns in 9 European countries. J Cataract Refract Surg 39:1421–1431CrossRefPubMed

52.

Hunyor AP, Merani R, Darbar A, Korobelnik J‑F, Lanzetta P, Okada AA (2017) Topical antibiotics and intravitreal injections. Acta Ophthalmol. https://doi.org/10.1111/aos.13417 PubMedCrossRef

53.

Nentwich MM, Ta CN, Kreutzer TC, Li B, Schwarzbach F, Yactayo-Miranda YM et al (2015) Incidence of postoperative endophthalmitis from 1990 to 2009 using povidone-iodine but no intracameral antibiotics at a single academic institution. J Cataract Refract Surg 41:58–66CrossRefPubMed

54.

Gower EW, Lindsley K, Tulenko SE, Nanji AA, Leyngold I, McDonnell PJ (2017) Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD006364.pub3 PubMedPubMedCentralCrossRef

55.

Bowen RC, Zhou AX, Bondalapati S, Lawyer TW, Snow KB, Evans PR et al (2018) Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis. Br J Ophthalmol. https://doi.org/10.1136/bjophthalmol-2017-311051 PubMedCrossRef

Titel: Endophthalmitis
verfasst von: PD Dr. Thomas Neß
Publikationsdatum: 25.05.2018
Verlag: Springer Medizin
Schlagwörter: Streptokokken
Antibiotika
Ceftazidim
Voriconazol
Vitrektomie
Erschienen in: Die Ophthalmologie / Ausgabe 8/2018
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI: https://doi.org/10.1007/s00347-018-0729-6

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2018

Bilateraler posteriorer persistierender hyperplastischer primärer Glaskörper

Biomechanische Untersuchungen zur Akkommodation des Auges

Empfehlungen der DOG für die Planung klinischer Studien im Auftrage Dritter

STARflo – ein suprachoroidales Drainageimplantat in der Glaukomchirurgie

Lebensbedrohliche Protrusio

Biomechanik in der Augenheilkunde